Andreas K Buck - Search Results

Year	Number of Results
2002	1
2003	4
2004	4
2005	4
2006	2
2007	7
2008	11
2009	8
2010	10
2011	9
2012	9
2013	11
2014	22
2015	14
2016	17
2017	18
2018	25
2019	20
2020	16
2021	18
2022	35
2023	32
2024	11

1

Prognostic Performance of RECIP 1.0 Based on [¹⁸F]PSMA-1007 PET in Prostate Cancer Patients Treated with [¹⁷⁷Lu]Lu-PSMA I&T.

Hartrampf PE, Hüttmann T, Seitz AK, Kübler H, Serfling SE, Higuchi T, Schlötelburg W, Michalski K, Gafita A, Rowe SP, Pomper MG, Buck AK, Werner RA. Hartrampf PE, et al. Among authors: buck ak. J Nucl Med. 2024 Apr 1;65(4):560-565. doi: 10.2967/jnumed.123.266702. J Nucl Med. 2024. PMID: 38453363

2

Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinoma.

Schlötelburg W, Hartrampf PE, Kosmala A, Fuss CT, Serfling SE, Buck AK, Schirbel A, Kircher S, Hahner S, Werner RA, Fassnacht M. Schlötelburg W, et al. Among authors: buck ak. Endocrine. 2024 Feb 21. doi: 10.1007/s12020-024-03695-6. Online ahead of print. Endocrine. 2024. PMID: 38381353

3

Exploring Theranostic Avenues in Adrenocortical Carcinoma Using Chemokine Receptor and Prostate-Specific Membrane Antigen-Directed PET/CT.

Hahner S, Higuchi T, Serfling SE, Samnick S, Fuss CT, Heinze B, Buck AK, Schirbel A, Fassnacht M, Werner RA. Hahner S, et al. Among authors: buck ak. Clin Nucl Med. 2024 Apr 1;49(4):369-370. doi: 10.1097/RLU.0000000000005083. Epub 2024 Feb 9. Clin Nucl Med. 2024. PMID: 38350087

4

Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine Carcinomas.

Michalski K, Schlötelburg W, Hartrampf P, Heinrich M, Serfling S, Buck AK, Werner RA, Kosmala A, Weich A. Michalski K, et al. Among authors: buck ak. Mol Imaging Biol. 2024 Apr;26(2):344-350. doi: 10.1007/s11307-024-01899-w. Epub 2024 Feb 8. Mol Imaging Biol. 2024. PMID: 38332341 Free PMC article.

5

Gallium-68-Labeled KISS1-54 Peptide for Mapping KISS1 Receptor via PET: Initial Evaluation in Human Tumor Cell Lines and in Tumor-Bearing Mice.

Israel I, Riehl G, Butt E, Buck AK, Samnick S. Israel I, et al. Among authors: buck ak. Pharmaceuticals (Basel). 2023 Dec 27;17(1):44. doi: 10.3390/ph17010044. Pharmaceuticals (Basel). 2023. PMID: 38256878 Free PMC article.

6

Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma.

Michalski K, Schlötelburg W, Hartrampf PE, Kosmala A, Buck AK, Hahner S, Schirbel A. Michalski K, et al. Among authors: buck ak. Pharmaceuticals (Basel). 2023 Dec 23;17(1):25. doi: 10.3390/ph17010025. Pharmaceuticals (Basel). 2023. PMID: 38256859 Free PMC article. Review.

7

Evaluating the Patterns of FAPI Uptake in the Shoulder Joint: a Preliminary Study Comparing with FDG Uptake in Oncological Studies.

Matsusaka Y, Werner RA, Serfling SE, Buck AK, Kosmala A, Sasaki T, Weich A, Higuchi T. Matsusaka Y, et al. Among authors: buck ak. Mol Imaging Biol. 2024 Apr;26(2):294-300. doi: 10.1007/s11307-023-01893-8. Epub 2024 Jan 4. Mol Imaging Biol. 2024. PMID: 38177615 Free PMC article.

8

[¹⁸F]FDG PET/CT can trigger relevant oncological management changes leading to favorable outcome in iodine-negative thyroid cancer patients.

Zhi Y, Higuchi T, Hackenberg S, Hagen R, Stöth M, Scherzad A, Buck AK, Werner RA, Serfling SE. Zhi Y, et al. Among authors: buck ak. Endocrine. 2023 Dec 22. doi: 10.1007/s12020-023-03645-8. Online ahead of print. Endocrine. 2023. PMID: 38133766

9

CXCR4-directed PET/CT with [⁶⁸ Ga]Ga-pentixafor in solid tumors-a comprehensive analysis of imaging findings and comparison with histopathology.

Dreher N, Hahner S, Fuß CT, Schlötelburg W, Hartrampf PE, Serfling SE, Schirbel A, Samnick S, Higuchi T, Weich A, Lapa C, Rosenwald A, Buck AK, Kircher S, Werner RA. Dreher N, et al. Among authors: buck ak. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1383-1394. doi: 10.1007/s00259-023-06547-z. Epub 2023 Dec 12. Eur J Nucl Med Mol Imaging. 2024. PMID: 38082196 Free PMC article.

10

C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Hematological Malignancies-Myeloablative Effects, Antilymphoma Activity, and Safety Profile.

Dreher N, Dörrler AL, Kraus S, Higuchi T, Serfling SE, Samnick S, Einsele H, Grigoleit GU, Buck AK, Werner RA. Dreher N, et al. Among authors: buck ak. Clin Nucl Med. 2024 Feb 1;49(2):146-151. doi: 10.1097/RLU.0000000000004974. Epub 2023 Nov 29. Clin Nucl Med. 2024. PMID: 38081189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

270 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Results by year